25/02/2026
Do you have Type 2 diabetes?
Are you on Dapagliflozin? - if not, you should be!
Millions of people with type 2 diabetes could live longer, healthier lives under new NICE recommendations that put individual needs at the heart of treatment decisions.
In final guidance published by NICE on Wednesday 18 February, people with type 2 diabetes will be offered a type of medicine called an SGLT-2 inhibitor, known as ‘flozins’, much earlier in their treatment. - Actually Zetland have been offering it early in treatment for many years now, as the evidence for this has been out for a while.
Analysis by NICE suggests using SGLT-2 medicines earlier in the treatment pathway, and the introduction of GLP-1 receptor agonists and tirzepatide for some people, could prevent around 17,000 deaths over a three-year period across the UK by reducing the risk of heart attacks, strokes and kidney problems.
So, ideally if you have Type 2 diabetes you should be on Metformin, Dapagliflozin and Atorvastatin. These 3 medications will slow your diabetes progression and prevent the illnesses diabetes cause.
If you want to chat about these medications please get in touch. We want our patients to live long and healthy lives